Casamento Charles J's Form 4 filing
Relmada Therapeutics, Inc. (RLMD) · filed Jul 16, 2021
- Accession no.
- 0001213900-21-037273
- Filed
- Jul 16, 2021
- Trade date
- Jul 15, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $104.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casamento Charles JCIK 0001117167 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Sales prices range from $30.66 to $31.60 per share, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
Sales prices range from $32.32 to $32.93 per share, inclusive
Referenced by the price of 1 transaction in Table I.